Proliferative Diabetic Retinopathy Market Global Industry Analysis, Share, Size, Growth, Trends and Forecast 2017 - 2026

Mar 2018| TMR323A| Transparency

Report Highlights

Proliferative diabetic retinopathy prevails as leading cause of blindness across industrialized countries worldwide. Although remarkable advancements have been made in the diagnosis and treatment of the disease, several imperative management questions as well as treatment deficiencies continue to persist unanswered. The diabetic pandemic has threatened overwhelming resources and increasing incidences of blindness, which in turn has necessitated the development of actionable programs for diagnosis and treatment of the disease as well as the diseases caused as a consequence of diabetes such as proliferative diabetic retinopathy.

The global proliferative diabetic retinopathy market has been thoroughly analyzed in the latest research report developed by Transparency Market Research, which issues in-depth insights on prominent factors impacting growth of the market. Growth prospects offered in the report are assessed for the period between 2017 and 2026, and the historical analysis on the market has been delivered for the period between 2012 and 2016.

The report issues analysis on key threats, opportunities, restrains and drivers of the proliferative diabetic retinopathy market’s growth, coupled with in-depth study on their likely influences on the market. Valuable qualitative information offered in the report can enable readers in acquiring a thorough understanding of impactful market dynamics. Apart from a comprehensive analysis on influential market dynamics, the report also encompasses the raw material sourcing strategies, pricing analysis, cost structure, and supply chain analysis on the global proliferative diabetic retinopathy market.

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

The report comprises a detailed segmentation-wise analysis on the global proliferative diabetic retinopathy market, which provides readers with better understanding about lucrative and sluggish avenues for the market expansion. The global market for proliferative diabetic retinopathy has been assessed across a range of segments viz. drug class, mode of administration, distribution channel, and region. Geographically, the market has been branched into Asia-Pacific excluding Japan, Latin America, Japan, Middle East & Africa, Europe, and North America.

TMR’s report on the global proliferative diabetic retinopathy market is expected to be beneficial for proliferative diabetic retinopathy drug manufacturers, as existing players can leverage the intelligence offered for making better business decisions. Players evaluating a market entry will gain necessary insights through this report. This report is expected to serve as pragmatic and comprehensive source of knowledge and insights, which will help key stakeholders to formulate their future business plans.

Detailed Assessment of Competition Landscape & Exhaustive Research Methodology

The report also encompasses an exhaustive chapter on the proliferative diabetic retinopathy market’s competition landscape, which gives a detailed profiling of key companies that offer significant contribution to the market growth. Along with in-depth discussion and analysis on the business and product development strategies of the market players comprised, the report also sheds light on financial performance of these companies, coupled with their recent developments over the past couple of years. This concluding chapter of the report is of high value to the report readers, as they can attain actionable insights on novel developmental and growth strategies employed by the market players. This will further help them in gauging their respective positioning in this highly competitive market.

  • Table 1 : Global Proliferative Diabetic Retinopathy Market Value (US$ Mn), 2012-2017
  • Table 2 : Global Proliferative Diabetic Retinopathy Market Value (US$ Mn), 2018-2026
  • Table 3 : Global Proliferative Diabetic Retinopathy Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • Table 4 : Global Anti-VEGF Agents Segment Value (US$ Mn), By Region 2012-2017
  • Table 5 : Global Anti-VEGF Agents Segment Value (US$ Mn), By Region 2018-2026
  • Table 6 : Global Anti-VEGF Agents Segment Market Share, By Region 2012-2017
  • Table 7 : Global Anti-VEGF Agents Segment Market Share, By Region 2018-2026
  • Table 8 : Global Anti-VEGF Agents Segment Y-o-Y, By Region 2017-2026
  • Table 9 : Global Corticosteroids Segment Value (US$ Mn), By Region 2012-2017
  • Table 10 : Global Corticosteroids Segment Value (US$ Mn), By Region 2018-2026
  • Table 11 : Global Corticosteroids Segment Market Share, By Region 2012-2017
  • Table 12 : Global Corticosteroids Segment Market Share, By Region 2018-2026
  • Table 13 : Global Corticosteroids Segment Y-o-Y, By Region 2017-2026
  • Table 14 : Global Injectables Segment Value (US$ Mn), By Region 2012-2017
  • Table 15 : Global Injectables Segment Value (US$ Mn), By Region 2018-2026
  • Table 16 : Global Injectables Segment Market Share, By Region 2012-2017
  • Table 17 : Global Injectables Segment Market Share, By Region 2018-2026
  • Table 18 : Global Injectables Segment Y-o-Y, By Region 2017-2026
  • Table 19 : Global Oral Segment Value (US$ Mn), By Region 2012-2017
  • Table 20 : Global Oral Segment Value (US$ Mn), By Region 2018-2026
  • Table 21 : Global Oral Segment Market Share, By Region 2012-2017
  • Table 22 : Global Oral Segment Market Share, By Region 2018-2026
  • Table 23 : Global Oral Segment Y-o-Y, By Region 2017-2026
  • Table 24 : Global Others Segment Value (US$ Mn), By Region 2012-2017
  • Table 25 : Global Others Segment Value (US$ Mn), By Region 2018-2026
  • Table 26 : Global Others Segment Market Share, By Region 2012-2017
  • Table 27 : Global Others Segment Market Share, By Region 2018-2026
  • Table 28 : Global Others Segment Y-o-Y, By Region 2017-2026
  • Table 29 : Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
  • Table 30 : Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
  • Table 31 : Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
  • Table 32 : Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
  • Table 33 : Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
  • Table 34 : Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
  • Table 35 : Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
  • Table 36 : Global Retail Pharmacies Segment Market Share, By Region 2012-2017
  • Table 37 : Global Retail Pharmacies Segment Market Share, By Region 2018-2026
  • Table 38 : Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
  • Table 39 : Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2017
  • Table 40 : Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2026
  • Table 41 : Global Online Pharmacies Segment Market Share, By Region 2012-2017
  • Table 42 : Global Online Pharmacies Segment Market Share, By Region 2018-2026
  • Table 43 : Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026
  • Table 44 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2012-2017
  • Table 45 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2018-2026
  • Table 46 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2012-2017
  • Table 47 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2018-2026
  • Table 48 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2012-2017
  • Table 49 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2018-2026
  • Table 50 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2012-2017
  • Table 51 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2018-2026
  • Table 52 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2012-2017
  • Table 53 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2018-2026
  • Table 54 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2012-2017
  • Table 55 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2018-2026
  • Table 56 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2012-2017
  • Table 57 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2018-2026
  • Table 58 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2012-2017
  • Table 59 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2018-2026
  • Table 60 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2012-2017
  • Table 61 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2018-2026
  • Table 62 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2012-2017
  • Table 63 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2018-2026
  • Table 64 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2012-2017
  • Table 65 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2018-2026
  • Table 66 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2012-2017
  • Table 67 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2018-2026
  • Table 68 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2012-2017
  • Table 69 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2018-2026
  • Table 70 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2012-2017
  • Table 71 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2018-2026
  • Table 72 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2012-2017
  • Table 73 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2018-2026
  • Table 74 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2012-2017
  • Table 75 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2018-2026
  • Table 76 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2012-2017
  • Table 77 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2018-2026
  • Table 78 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2012-2017
  • Table 79 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2018-2026
  • Table 80 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2012-2017
  • Table 81 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2018-2026
  • Table 82 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2012-2017
  • Table 83 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2018-2026
  • Table 84 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2012-2017
  • Table 85 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2018-2026
  • Table 86 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2012-2017
  • Table 87 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2018-2026
  • Table 88 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2012-2017
  • Table 89 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2018-2026
  • Table 90 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2012-2017
  • Table 91 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2018-2026
  • Figure 1 : Global Proliferative Diabetic Retinopathy Market Value (US$ Mn), 2012-2017
  • Figure 2 : Global Proliferative Diabetic Retinopathy Market Value (US$ Mn) Forecast, 2018-2026
  • Figure 3 : Global Proliferative Diabetic Retinopathy Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • Figure 4 : Global Anti-VEGF Agents Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 5 : Global Anti-VEGF Agents Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 6 : Global Anti-VEGF Agents Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 7 : Global Corticosteroids Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 8 : Global Corticosteroids Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 9 : Global Corticosteroids Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 10 : Global Injectables Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 11 : Global Injectables Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 12 : Global Injectables Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 13 : Global Oral Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 14 : Global Oral Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 15 : Global Oral Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 16 : Global Others Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 17 : Global Others Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 18 : Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 19 : Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 20 : Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 21 : Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 22 : Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 23 : Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 24 : Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 25 : Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 26 : Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 27 : Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 28 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2012-2017
  • Figure 29 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2018-2026
  • Figure 30 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2012-2017
  • Figure 31 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2018-2026
  • Figure 32 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2012-2017
  • Figure 33 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2018-2026
  • Figure 34 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2012-2017
  • Figure 35 : North America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2018-2026
  • Figure 36 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2012-2017
  • Figure 37 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2018-2026
  • Figure 38 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2012-2017
  • Figure 39 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2018-2026
  • Figure 40 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2012-2017
  • Figure 41 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2018-2026
  • Figure 42 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2012-2017
  • Figure 43 : Latin America Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2018-2026
  • Figure 44 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2012-2017
  • Figure 45 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2018-2026
  • Figure 46 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2012-2017
  • Figure 47 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2018-2026
  • Figure 48 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2012-2017
  • Figure 49 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2018-2026
  • Figure 50 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2012-2017
  • Figure 51 : Europe Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2018-2026
  • Figure 52 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2012-2017
  • Figure 53 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2018-2026
  • Figure 54 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2012-2017
  • Figure 55 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2018-2026
  • Figure 56 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2012-2017
  • Figure 57 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2018-2026
  • Figure 58 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2012-2017
  • Figure 59 : Japan Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2018-2026
  • Figure 60 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2012-2017
  • Figure 61 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2018-2026
  • Figure 62 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2012-2017
  • Figure 63 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2018-2026
  • Figure 64 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2012-2017
  • Figure 65 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2018-2026
  • Figure 66 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2012-2017
  • Figure 67 : APEJ Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2018-2026
  • Figure 68 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2012-2017
  • Figure 69 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Country 2018-2026
  • Figure 70 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2012-2017
  • Figure 71 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Drug Class 2018-2026
  • Figure 72 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2012-2017
  • Figure 73 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Mode of Administration 2018-2026
  • Figure 74 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2012-2017
  • Figure 75 : MEA Proliferative Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel 2018-2026

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report